Subtype-specific transcription factors are clinically relevant and show distinct therapeutic vulnerabilities in human small cell lung cancer
C Lang, Z Megyesfalvi, B Szeitz, A Lantos, N Woldmar, Z Valko, A Schwendenwein, F Oberndorfer, N Barany, S Paku, V Laszlo, H Kiss, E Bugyik, B Ferencz, K Dezso, Z Lohinai, J Moldvay, J Fillinger, G Galffy, C Rivard, F R Hirsch, L Brcic, H Popper, I Kern, M Kovacevic, J Skarda, M Mittak, A M Szasz, L Pizzatti, K Bogos, M A Hoda, K Hoetzenecker, G Marko-Varga, P Horvatovics, F Renyi-Vamos, T Klikovits, K Schelch, M Rezeli, B Döme
European Respiratory Journal Sep 2022, 60 (suppl 66) 3828; DOI: 10.1183/13993003.congress-2022.3828
